PeptideDB

IVHD-valtrate

CAS No.: 28325-56-6

VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeut
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent.
molecular weight 540.6
Molecular formula C27H40O11
CAS 28325-56-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year